Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters

Berlin 13581

0 studies enrolling now · 3 studies all time

What they study most

Triple Negative Breast Cancer, Triple-Negative Breast Cancer, Triple-negative Breast Cancer

Studies at this site

• A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) — Completed
• A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer — Completed
• A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) — Completed